FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3024979105> ?p ?o ?g. }

• W3024979105 endingPage "781" @default.
• W3024979105 startingPage "781" @default.
• W3024979105 abstract "A new six intraperitoneal injections insulin-mimetic vanadyl(IV) compounds [(VO)(FA)(AAn)] (where n = 1–6: AA1 = isoleucine, AA2 = threonine, AA3 = proline, AA4 = phenylalanine, AA5 = lysine, and AA6 = glutamine) were synthesized by the chemical reactions between folic acid (FA), VOSO4, and amino acids (AAn) with equal molar ratio 1:1:1 in neutralized media. These complexes were characterized by elemental analysis and estimation of vanadyl(IV) metal ions. The thermal stability behavior of these complexes was studied by TG-DTG-DTA analyses. The structures of these complexes were elucidated by spectroscopic methods like infrared, electron spin resonance (ESR), and solid reflectance spectroscopes. The powder X-ray diffraction (XRD) study suggested the crystalline nature of the complexes. Magnetic moments and electronic spectra revealed the square-pyramid geometrical structure of the complexes. The conductivity results refereed that all synthesized vanadyl(IV) complexes were of a non-electrolyte behavior. The infrared spectra assignments of these complexes revealed that the FAH2 and AAn chelates act as a bidentate ligation. The chelation towards vanadyl (IV) ions existed via deprotonation of one of the carboxylic groups of FAH2 drug ligand, and so amino acids act as bidentate ligands via N-amino and O-carboxylate groups. Both scanning and transmission electron microscope (SEM and TEM) techniques were used to investigate the surface morphology. The main task of this research is the aim of designing a new insulin alternative antidiabetic drug agent. The antidiabetic efficiency of these complexes was evaluated in streptozotocin-induced diabetic male albino rats. Liver and kidney functions, insulin and blood glucose levels, lipid profile, and superoxide dismutase antioxidant (SOD) are verified identifiers for the efficiency of VO(IV)/FA/AAn system compounds as antidiabetic drug agents." @default.
• W3024979105 created "2020-05-21" @default.
• W3024979105 creator A5022751431 @default.
• W3024979105 creator A5032483174 @default.
• W3024979105 creator A5044302609 @default.
• W3024979105 creator A5053398384 @default.
• W3024979105 creator A5056934831 @default.
• W3024979105 creator A5057566854 @default.
• W3024979105 creator A5067927306 @default.
• W3024979105 creator A5067938732 @default.
• W3024979105 creator A5076205185 @default.
• W3024979105 date "2020-05-18" @default.
• W3024979105 modified "2023-10-14" @default.
• W3024979105 title "Synthesis, Characterization, and Anti-diabetic Activity of Some Novel Vanadium-Folate-Amino Acid Materials" @default.
• W3024979105 cites W1597576404 @default.
• W3024979105 cites W1980022949 @default.
• W3024979105 cites W1981109252 @default.
• W3024979105 cites W1988983679 @default.
• W3024979105 cites W1997225314 @default.
• W3024979105 cites W1998722626 @default.
• W3024979105 cites W2006084757 @default.
• W3024979105 cites W2006258314 @default.
• W3024979105 cites W2023162409 @default.
• W3024979105 cites W2025008399 @default.
• W3024979105 cites W2031263343 @default.
• W3024979105 cites W2047431913 @default.
• W3024979105 cites W2053535968 @default.
• W3024979105 cites W2056610456 @default.
• W3024979105 cites W2058572415 @default.
• W3024979105 cites W2061613866 @default.
• W3024979105 cites W2063267040 @default.
• W3024979105 cites W2063606043 @default.
• W3024979105 cites W2066745750 @default.
• W3024979105 cites W2067993269 @default.
• W3024979105 cites W2075155393 @default.
• W3024979105 cites W2075590923 @default.
• W3024979105 cites W2078769631 @default.
• W3024979105 cites W2079680060 @default.
• W3024979105 cites W2081045003 @default.
• W3024979105 cites W2082292235 @default.
• W3024979105 cites W2093652930 @default.
• W3024979105 cites W2100466037 @default.
• W3024979105 cites W2122955899 @default.
• W3024979105 cites W2124695577 @default.
• W3024979105 cites W2137122025 @default.
• W3024979105 cites W2161191735 @default.
• W3024979105 cites W2165091126 @default.
• W3024979105 cites W2170499962 @default.
• W3024979105 cites W2349550694 @default.
• W3024979105 cites W2739369667 @default.
• W3024979105 cites W2773418970 @default.
• W3024979105 cites W2774787384 @default.
• W3024979105 cites W2804749510 @default.
• W3024979105 cites W2804822699 @default.
• W3024979105 cites W2807893467 @default.
• W3024979105 cites W2861347695 @default.
• W3024979105 cites W2894870569 @default.
• W3024979105 cites W2903998393 @default.
• W3024979105 cites W2905975968 @default.
• W3024979105 cites W2909918690 @default.
• W3024979105 cites W2938936128 @default.
• W3024979105 cites W2939810236 @default.
• W3024979105 cites W2941266747 @default.
• W3024979105 cites W2943611993 @default.
• W3024979105 cites W2946373057 @default.
• W3024979105 cites W2951812581 @default.
• W3024979105 cites W2955626586 @default.
• W3024979105 cites W4206104240 @default.
• W3024979105 cites W4232867939 @default.
• W3024979105 cites W4250193201 @default.
• W3024979105 doi "https://doi.org/10.3390/biom10050781" @default.
• W3024979105 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7277503" @default.
• W3024979105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32443614" @default.
• W3024979105 hasPublicationYear "2020" @default.
• W3024979105 type Work @default.
• W3024979105 sameAs 3024979105 @default.
• W3024979105 citedByCount "7" @default.
• W3024979105 countsByYear W30249791052022 @default.
• W3024979105 countsByYear W30249791052023 @default.
• W3024979105 crossrefType "journal-article" @default.
• W3024979105 hasAuthorship W3024979105A5022751431 @default.
• W3024979105 hasAuthorship W3024979105A5032483174 @default.
• W3024979105 hasAuthorship W3024979105A5044302609 @default.
• W3024979105 hasAuthorship W3024979105A5053398384 @default.
• W3024979105 hasAuthorship W3024979105A5056934831 @default.
• W3024979105 hasAuthorship W3024979105A5057566854 @default.
• W3024979105 hasAuthorship W3024979105A5067927306 @default.
• W3024979105 hasAuthorship W3024979105A5067938732 @default.
• W3024979105 hasAuthorship W3024979105A5076205185 @default.
• W3024979105 hasBestOaLocation W30249791051 @default.
• W3024979105 hasConcept C116569031 @default.
• W3024979105 hasConcept C118629725 @default.
• W3024979105 hasConcept C13965031 @default.
• W3024979105 hasConcept C145148216 @default.
• W3024979105 hasConcept C170493617 @default.
• W3024979105 hasConcept C178790620 @default.
• W3024979105 hasConcept C179104552 @default.
• W3024979105 hasConcept C185592680 @default.

• next